首页> 外文期刊>Pharmacology & Pharmacy >Development and Application of a Validated UHPLC Method for the Determination of Atropine and Its Major Impurities in Antidote Treatment Nerve Agent Auto-Injectors (ATNAA) Stored in the Strategic National Stockpiles
【24h】

Development and Application of a Validated UHPLC Method for the Determination of Atropine and Its Major Impurities in Antidote Treatment Nerve Agent Auto-Injectors (ATNAA) Stored in the Strategic National Stockpiles

机译:验证的UHPLC方法在国家战略储备库中的解毒剂治疗神经毒剂自动注射器(ATNAA)中测定阿托品及其主要杂质的方法的开发和应用

获取原文
       

摘要

The development and implementation of advanced analytical technologies is essential for extending the expiry for complex drug products stored in the Strategic National Stockpiles. Consequently, a novel Ultra High-Performance Liquid Chromatographic (UHPLC) method has been developed for the analysis of atropine and its respective impurities to support the analytical research platform for auto-injectors. This study is part of a larger research effort to improve the efficiency and broaden the applicability of advanced analytical methods for medical counter-measure medications. The current HPLC compendial methodology for atropine sulfate injection requires an analysis time of 40 minutes for atropine. In comparison, the novel gradient UHPLC method required only 8 minutes to evaluate both atropine and its major pharmaceutical impurities. Improved separation was achieved on a Waters Acquity UHPLC BEH C18 1.7 μm, 2.1 × 100 mm column employing gradient elution of mobile phase solvent A (0.1% H3PO4) and solvent B (0.1% H3PO4, 90% ACN, and 10% H2O). The method was validated according to USP Category I requirements for assay. The daily standard calibration curves were linear over a concentration range from 50 μg/mL to 250 μg/mL with a correlation coefficient of >0.999. The detection limit (LOD) and quantitation limit (LOQ) were 3.9 μg/ml and 13.1 μg/ml, respectively. Resolution results indicate that atropine and the following impurities, degradants and a preservative can also be separated and analyzed using this proposed method: noratropine, 4,4’-di-hy-droxydiphenyl ether, 2,4’-dihydroxydiphenyl ether, 4-bromophenol, 4-hydro-xyatropine, tropic acid, apoatropine HCl, atropic acid, hydroquinone, nitroethane, phenol and catechol. The UHPLC method demonstrated enhanced selectivity and significantly reduced the analysis time when compared with the traditional USP compendial HPLC method. The method was successfully applied to the evaluation of atropine in ATNAA auto-injectors lots from the Strategic National Stockpiles.
机译:先进分析技术的开发和实施对于延长战略国家库存中存储的复杂药品的有效期至关重要。因此,已经开发了一种新颖的超高效液相色谱(UHPLC)方法来分析阿托品及其各自的杂质,以支持自动注射器的分析研究平台。这项研究是一项大型研究工作的一部分,旨在提高效率并扩大先进的医学对策药物分析方法的适用性。当前用于注射硫酸阿托品的HPLC药典方法要求阿托品的分析时间为40分钟。相比之下,新型梯度UHPLC方法仅需8分钟即可评估阿托品及其主要药物杂质。使用流动相溶剂A(0.1%H3PO4)和溶剂B(0.1%H3PO4、90%ACN和10%H2O)的梯度洗脱,在Waters Acquity UHPLC BEH C18 1.7μm,2.1×100 mm色谱柱上实现了更好的分离。该方法已根据USP I类分析要求进行了验证。每日标准校准曲线在50μg/ mL至250μg/ mL的浓度范围内呈线性,相关系数> 0.999。检出限(LOD)和定量限(LOQ)分别为3.9μg/ ml和13.1μg/ ml。拆分结果表明,使用该拟议方法还可以分离和分析阿托品及其以下杂质,降解物和防腐剂:去甲酚,4,4'-二羟基二苯醚,2,4'-二羟基二苯醚,4-溴苯酚,4-氢邻苯二酚,对苯二甲酸,盐酸阿托品酸,对苯二酸,对苯二酚,硝基乙烷,苯酚和邻苯二酚。与传统的USP药典HPLC方法相比,UHPLC方法具有更高的选择性并大大减少了分析时间。该方法已成功应用于来自国家战略储备库的ATNAA自动注射器批次中的阿托品评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号